Rheumatology Medical News about Ankylosing Spondylitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Anti Tumor Necrosis Factor Alpha (TNF) Therapy in Ankylosing Spondylitis - Asian Perspective
Current Rheumatology Reviews, 09/10/09

Lee TY et al. – Ankylosing spondylitis (AS) is the prototype of spondyloarthritides. The diagnosis of AS is often delayed until late stage with radiographic damage. The development of anti–TNFalpha therapy has been an important therapeutic advance in AS. The efficacy of anti–TNFalpha therapy is indubitable in short term and up to five years in published studies in both western countries and Asia.

<< Previous
Other Future Targeting Therapy Beyond TNF-alpha Inhibitor in...

Next >>
African Americans and Whites Are Equally Appropriate to be...

Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09 Relevance Score: 69%

Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09 Relevance Score: 68%

Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism
Rheumatology International, 11/11/09 Relevance Score: 67%

Concomitant cervical and thoracic spinal fractures in ankylosing spondylitis: A case report and review of literature
Injury Extra, 11/05/09 Relevance Score: 67%

A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09 Relevance Score: 67%